This business report provides a comprehensive view of the pharmaceutical industry and its top 10 companies..

The report includes the following:

– Industry analysis including market value, market volume, market share and forecast growth till 2013

– Assessment of intensity of competition based on five-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power

– SWOT and 5-year financial analysis of top 10 players in the industry

– Descriptive profiles of the leading players including the strategic initiatives undertaken in the last 12 months

The top 10 companies have been ascertained based on their global revenues for the year ended December 2008.

Highlights:

The global pharmaceuticals industry generated total revenues of $615.1 billion in 2008, representing a compound annual growth rate (CAGR) of 4.7% for the period spanning 2004–08. The industry's total revenues are expected to touch $734 billion by the end of 2013, representing a CAGR of 3.6% for the 2008–13 period.

The top 10 global pharmaceutical companies recorded revenues of $348.3 billion during 2008, an increase of 4% over 2007. The operating profit of these companies was $81.6 billion during 2008, an increase of 11.6% over 2007. The net profit was $65.1 billion in 2008, an increase of 12.1% over 2007.

The average operating margin of the top 10 companies was 23.3% in 2008 as compared to 23.1% in 2007. The net margin was 20.2% in 2008 as compared with 19.3% in 2007.

Since 2004, the global pharmaceuticals market has witnessed moderate growth across different geographies. The market growth is expected to decelerate through to 2013 due to increased number of patent expiries and intensifying competition from generics.

Reasons to Purchase:

– Gain insights into the industry, leading companies and competitors through a single report

– Benchmark the leading players using 5-year financial analysis, ratios and adjusted financial statement data

– Form opinions about key players using SWOT Analysis to understand internal factors (strengths and weaknesses) and external factors (opportunities and threats) influencing the companies

– Determine industry attractiveness from five-forces analysis of constituent segments

Table of Contents



119 pages

Publication Date : June 2009